High Prices For Orphan Drugs Strain Families And Insurers
Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked but at a high cost.
Read more on NPR
January 18, 2017 at 01:35AM
Health Care
NPR News: High Prices For Orphan Drugs Strain Families And Insurers
Related Posts:
NPR News: Slice, Dice, Chop Or Julienne: Does The Cut Change The Flavor?- NPR News: Hassle Of Being A Patient Can Turn Into A Crisis Without Sick Leave
- NPR News: Hassle Of Being A Patient Can Turn Into A Crisis Without Sick Leave
- NPR News: 'I'm A Student-Debt Slave.' How'd We Get Here?
- NPR News: Climate Change May Already Be Shifting Clouds Toward The Poles
0 nhận xét:
Đăng nhận xét